What to expect at Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Experts share insights in “The evolving strategies for managing nAMD and DME” session at Las Vegas event

For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories

Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach.”

Prime's Sneha Sharma and Michael Szatkowski present “A beginner’s guide to decoding cell and gene therapy” educational session at event in Las Vegas, Nevada

Nick Friedlander, clinical program pharmacist at Prime, shares more about two research studies that convey the impact of one cost-savings solution.

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

Lead authors Erin Ventura and Alina Liang share more about the study “Evaluating the 10-Year Impact of an Immunoglobulin Utilization Management and Dose Optimization Program in the Managed Care...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

Live updates from AMCP Annual Meeting

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Event features discussions about health care industry trends, best practices and innovations

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

A look at the specialty landscape and how Prime delivers value to employers

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Managed Markets Insight & Technology (MMIT)

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.